Research Site
Livingston, New Jersey 07039
2 studies enrolling now · 14 studies all time
What they study most
AMR, Anemia, Anemia in Chronic Kidney Disease Patients Not on Dialysis, Antibody-Mediated Rejection, Biopsy-proven Histologic Scores, Carcinoma, Chronic Kidney Disease, DGF, Delayed Graft Function, Hyperparathyroidism, Hyperparathyroidism, Secondary, Hypertension
Studies at this site
- Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation — Recruiting now
- Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation — Recruiting now
- Dimethyl Fumarate (DMF) Observational Study — Completed
- Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease — Stopped early
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease — Completed
- Pediatric Chronic Kidney Disease Safety and Efficacy — Stopped early
- 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects — Completed
- Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function — Completed
- JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab — Completed
- An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes — Completed
- The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer — Completed
- Study to Evaluate the Prospective Payment System — Completed
- Iressa Expanded Access Program (EAP) — Completed
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects — Completed